InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,620.85
(
0.42%
)
US TECH 100
19,300.00
(
0.00%
)
Dow Jones
40,890.49
(
0.14%
)
Brent Oil
75.58
(
-0.15%
)
Bitcoin
60,797.66
(
3.03%
)
Post# of 252939
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 837
Posts 120317
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: mcbio post# 96433

Wednesday, 05/26/2010 11:01:04 PM

Wednesday, May 26, 2010 11:01:04 PM

Post# of 252939
ANDS translation: “We shopped ANA598 to every company who’s even remotely interested in HCV, but there were no takers. WTF do we do now?”

Answer: Raise more cash. This deal brings in $11.3M of net proceeds (5.8M sh @$2.15, less the banker’s placement fee):

http://finance.yahoo.com/news/Anadys-Pharmaceuticals-Inc-prnews-2488284349.html?x=0&.v=1

Lazard gets paid by ANDS for the direct placement as well as getting paid for the “strategic review.” Nice work if you can get it.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up